4100 Results
5
UC selected to test new vaccine
June 19, 2019
UC will serve as one of several international locations to test an investigational vaccine to possibly treat cytomegalovirus in people getting kidney transplants. The study is designed to learn more about the safety and effectiveness of the HB-101 vaccine at preventing the CMV infection in people who are CMV-negative who receive kidney transplants from living donors who are CMV-positive.